Interactive Financial Charts Not Available

Ortin Laboratories (ORTINLAB) | Financial Analysis & Statements

Ortin Laboratories Limited | Small-cap | Healthcare

₹16.38

5.00%

Ortin Laboratories vs Sun Pharmaceutical Ortin Laboratories vs Divi's Laboratories Ortin Laboratories vs Sun Pharma Advanced Ortin Laboratories vs Aarti Drugs Ortin Laboratories vs Unichem Laboratories Ortin Laboratories vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2024

Income Metrics

Revenue 2.1M

Gross Profit 1.0M 49.09%

Operating Income -1.0M -48.51%

Net Income -1.0M -49.38%

EPS (Diluted) ₹-0.13

Balance Sheet Metrics

Total Assets 182.3M

Total Liabilities 84.7M

Shareholders Equity 97.6M

Debt to Equity 0.87

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Ortin Laboratories Income Statement From 2021 to 2023

Metric	2023	2022	2021
Revenue i	60.2M	82.3M	81.7M
Cost of Goods Sold i	33.9M	46.5M	39.5M
Gross Profit i	26.3M	35.8M	42.2M
Gross Margin % i	43.7%	43.5%	51.6%
Operating Expenses
Research & Development i	-	-	-
Selling, General & Administrative i	3.1M	7.5M	5.8M
Other Operating Expenses i	12.6M	11.2M	10.9M
Total Operating Expenses i	15.7M	18.8M	16.7M
Operating Income i	3.1M	2.5M	9.6M
Operating Margin % i	5.2%	3.0%	11.8%
Non-Operating Items
Interest Income i	196.0K	33.0K	496
Interest Expense i	4.0M	7.9M	7.8M
Other Non-Operating Income	-	-	-
Pre-tax Income i	-1.1M	-5.3M	1.4M
Income Tax i	-169.0K	-1.3M	-8.1M
Effective Tax Rate % i	0.0%	0.0%	-592.9%
Net Income i	-936.0K	-4.0M	9.5M
Net Margin % i	-1.6%	-4.8%	11.6%
Key Metrics
EBITDA i	5.6M	5.5M	12.0M
EPS (Basic) i	₹-0.12	₹-0.49	₹1.16
EPS (Diluted) i	₹-0.12	₹-0.49	₹1.16
Basic Shares Outstanding i	7800000	8136735	8150445
Diluted Shares Outstanding i	7800000	8136735	8150445

Income Statement Trend

Ortin Laboratories Balance Sheet From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Assets
Current Assets
Cash & Equivalents i	2.2M	4.9M	251.3K	9.5M	8.9M
Short-term Investments i	361.0K	1.0M	1.5M	15.5M	-
Accounts Receivable i	34.2M	32.4M	39.1M	371.5M	378.3M
Inventory i	26.0M	17.4M	18.3M	499.0M	369.6M
Other Current Assets	2.6M	1.8M	2.0M	469.0K	1.0K
Total Current Assets i	65.4M	57.5M	61.3M	924.1M	820.4M
Non-Current Assets
Property, Plant & Equipment i	7.7M	7.7M	7.7M	224.5M	13.0M
Goodwill i	0	0	0	-	-
Intangible Assets i	-	-	-	-	-
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	-1.0K	-1.0K	-	-2.0K	-
Total Non-Current Assets i	146.6M	149.6M	151.4M	241.1M	230.5M
Total Assets i	212.0M	207.0M	212.7M	1.2B	1.1B
Liabilities
Current Liabilities
Accounts Payable i	15.5M	7.9M	13.4M	600.0M	476.0M
Short-term Debt i	34.8M	44.2M	55.0M	206.6M	207.3M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	18.5M	-1	8.0M	-	-1.0K
Total Current Liabilities i	69.8M	76.1M	78.9M	838.3M	683.3M
Non-Current Liabilities
Long-term Debt i	29.6M	17.3M	14.4M	49.0M	47.4M
Deferred Tax Liabilities i	2.5M	2.7M	4.0M	25.4M	25.5M
Other Non-Current Liabilities	-	21.0K	20.7K	20.7K	20.0K
Total Non-Current Liabilities i	33.5M	21.4M	20.2M	88.7M	47.4M
Total Liabilities i	103.3M	97.5M	99.1M	927.0M	730.7M
Equity
Common Stock i	81.3M	81.3M	81.3M	169.4M	169.4M
Retained Earnings i	20.9M	21.8M	25.8M	60.2M	73.0M
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	108.6M	109.6M	113.6M	238.2M	242.4M
Key Metrics
Total Debt i	64.5M	61.4M	69.4M	255.7M	254.7M
Working Capital i	-4.4M	-18.6M	-17.6M	85.9M	137.1M

Balance Sheet Composition

Ortin Laboratories Cash Flow Statement From 2021 to 2023

Metric	2023	2022	2021
Operating Activities
Net Income i	-1.1M	-5.3M	1.4M
Depreciation & Amortization i	-	-	-
Stock-Based Compensation i	-	-	-
Working Capital Changes i	-15.4M	23.2M	772.3M
Operating Cash Flow i	-12.5M	25.9M	782.4M
Investing Activities
Capital Expenditures i	82.0K	-1.3M	0
Acquisitions i	-	-	-
Investment Purchases i	-	-	0
Investment Sales i	-	-	696.0K
Investing Cash Flow i	82.0K	-1.3M	696.0K
Financing Activities
Share Repurchases i	-	0	-69.2M
Dividends Paid i	-	-	-
Debt Issuance i	-	-	-
Debt Repayment i	-	-	-
Financing Cash Flow i	671.0K	477.0K	-55.2M
Free Cash Flow i	-2.5M	20.2M	180.3M
Net Change in Cash i	-11.8M	25.2M	727.9M

Cash Flow Trend

Ortin Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 48.33

Price to Book 5.86

Price to Sales 22.11

PEG Ratio -0.64

Profitability Ratios

Profit Margin 43.70%

Operating Margin -49.76%

Return on Equity -0.86%

Return on Assets -0.44%

Financial Health

Current Ratio 0.67

Debt to Equity 63.82

Beta 1.36

Per Share Data

EPS (TTM) ₹-10.04

Book Value per Share ₹3.48

Revenue per Share ₹0.93

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
ortinlab	165.6M	48.33	5.86	-0.86%	43.70%	63.82
Sun Pharmaceutical	3.9T	37.59	5.41	15.08%	19.29%	3.26
Divi's Laboratories	1.7T	77.17	11.28	15.35%	23.41%	0.03
Sun Pharma Advanced	48.6B	-14.20	-	157.88%	-45.53%	-1.24
Aarti Drugs	44.7B	23.70	3.27	12.28%	7.80%	44.92
Unichem Laboratories	42.8B	31.15	1.75	5.63%	6.52%	18.76

Financial data is updated regularly. All figures are in the company's reporting currency.